Clinical Trial Update: Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating completion of ferumoxytol evaluation for iron-deficiency anemia in chronic kidney disease patients, including those on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: Georges Ouellet | Conditions: Iron-Deficiency Anemia, Inflammation | Phase 4 | Status: COMPLETED